Abstract:Background
Adequate gestational weight gain (GWG) is essential for healthy fetal growth. However, in low- and middle-income countries, where malnutrition is prevalent, little information is available about GWG and how it might be modified by nutritional status and interventions.
Objective
We describe GWG and its associations with fetal growth and birth outcomes. We also examined the extent to which prepregnancy BMI, and preco… Show more
“…Poor fetal growth has been associated with an increased risk of mortality, morbidity, and adverse neurodevelopmental consequences later in life [4, 5, 7], whereas excessive fetal growth has been associated with poor maternal perinatal outcomes (e.g., cesarean section) and childhood obesity [1, 28]. The associations of GWG with birth length and head circumference, however, have rarely been evaluated [23, 29, 30]. Inadequate GWG in this study was positively associated with the risk of stunting and microcephaly at birth.…”
Section: Discussionmentioning
confidence: 99%
“…A longitudinal study of 670 pregnant women in The Gambia similarly found that greater GWG at any level was positively associated with head circumference, but only greater GWG above a threshold of 0.5 SD of conditional weight gain (i.e., greater than the expected change in weight in a 3-month interval) was associated with higher birthweight and length, suggesting that better maternal nutrition (as measured by higher GWG) may be prioritized for brain growth over other anthropometric parameters [23]. Secondary data from analysis of a multicountry prenatal nutrition supplementation trial conducted in the Democratic Republic of the Congo, Guatemala, India, and Pakistan also found that higher GWG in the first trimester and higher GWG velocity overall were positively associated with birth length and weight [29].…”
Introduction: Gestational weight gain (GWG) is associated with fetal and newborn health; however, data from sub-Saharan Africa are limited.
Methods: We used data from a prenatal micronutrient supplementation trial among a cohort of HIV-negative pregnant women in Dar es Salaam, Tanzania to estimate the relationships between GWG and newborn outcomes. GWG adequacy was defined as the ratio of the total observed weight gain over the recommended weight gain based on the Institute of Medicine body mass index (BMI)-specific guidelines. Newborn outcomes assessed were: stillbirth, perinatal death, preterm birth, low birthweight, macrosomia, small-for-gestational age (SGA), large-for-gestational age (LGA), stunting at birth, and microcephaly. Modified Poisson regressions with robust standard error were used to estimate the relative risk of newborn outcomes as a function of GWG adequacy.
Results: Of 7561 women included in this study, 51% had severely inadequate (<70%) or inadequate GWG (70-90%), 31% had adequate GWG (90-125%), and 18% had excessive GWG (≥125%). Compared to adequate GWG, severely inadequate GWG was associated with a higher risk of low birthweight, SGA, stunting at birth, and microcephaly; whereas excessive GWG was associated with a higher risk of LGA and macrosomia.
Conclusion: Interventions to support optimal gestational weight gain are needed and are likely to improve newborn outcomes.
“…Poor fetal growth has been associated with an increased risk of mortality, morbidity, and adverse neurodevelopmental consequences later in life [4, 5, 7], whereas excessive fetal growth has been associated with poor maternal perinatal outcomes (e.g., cesarean section) and childhood obesity [1, 28]. The associations of GWG with birth length and head circumference, however, have rarely been evaluated [23, 29, 30]. Inadequate GWG in this study was positively associated with the risk of stunting and microcephaly at birth.…”
Section: Discussionmentioning
confidence: 99%
“…A longitudinal study of 670 pregnant women in The Gambia similarly found that greater GWG at any level was positively associated with head circumference, but only greater GWG above a threshold of 0.5 SD of conditional weight gain (i.e., greater than the expected change in weight in a 3-month interval) was associated with higher birthweight and length, suggesting that better maternal nutrition (as measured by higher GWG) may be prioritized for brain growth over other anthropometric parameters [23]. Secondary data from analysis of a multicountry prenatal nutrition supplementation trial conducted in the Democratic Republic of the Congo, Guatemala, India, and Pakistan also found that higher GWG in the first trimester and higher GWG velocity overall were positively associated with birth length and weight [29].…”
Introduction: Gestational weight gain (GWG) is associated with fetal and newborn health; however, data from sub-Saharan Africa are limited.
Methods: We used data from a prenatal micronutrient supplementation trial among a cohort of HIV-negative pregnant women in Dar es Salaam, Tanzania to estimate the relationships between GWG and newborn outcomes. GWG adequacy was defined as the ratio of the total observed weight gain over the recommended weight gain based on the Institute of Medicine body mass index (BMI)-specific guidelines. Newborn outcomes assessed were: stillbirth, perinatal death, preterm birth, low birthweight, macrosomia, small-for-gestational age (SGA), large-for-gestational age (LGA), stunting at birth, and microcephaly. Modified Poisson regressions with robust standard error were used to estimate the relative risk of newborn outcomes as a function of GWG adequacy.
Results: Of 7561 women included in this study, 51% had severely inadequate (<70%) or inadequate GWG (70-90%), 31% had adequate GWG (90-125%), and 18% had excessive GWG (≥125%). Compared to adequate GWG, severely inadequate GWG was associated with a higher risk of low birthweight, SGA, stunting at birth, and microcephaly; whereas excessive GWG was associated with a higher risk of LGA and macrosomia.
Conclusion: Interventions to support optimal gestational weight gain are needed and are likely to improve newborn outcomes.
“…In LMICs, improved GWG (100 g/wk) was associated with significantly improved birthweight and length, as was baseline prepregnancy BMI, early weight gain, and GWG from 12 to 32 weeks of gestation. 174 …”
Section: Growing Evidence Indicates That Maternal Prepregnancy Body M...mentioning
“…These changes, together with those observed in Ruminococcaceae and Lachnospiraceae in Guatemala, suggest that these putative SCFA-producing bacteria may be related to glycemic control during pregnancy, and a reduction in abundance might be beneficial for glucose regulation. In the WF participants, who on average had relatively low gestational weight gain and BMI ( Bauserman et al, 2021 ), these genera decreased during pregnancy. Future research, for example, utilizing germ-free mice, is needed to explore the potential causal relation between these SCFA producers and glycemic control during pregnancy.…”
ObjectiveTo characterize the changes in gut microbiota during pregnancy and determine the effects of nutritional intervention on gut microbiota in women from sub-Saharan Africa (the Democratic Republic of the Congo, DRC), South Asia (India and Pakistan), and Central America (Guatemala).MethodsPregnant women in the Women First (WF) Preconception Maternal Nutrition Trial were included in this analysis. Participants were randomized to receive a lipid-based micronutrient supplement either ≥3 months before pregnancy (Arm 1); started the same intervention late in the first trimester (Arm 2); or received no nutrition supplements besides those self-administered or prescribed through local health services (Arm 3). Stool and blood samples were collected during the first and third trimesters. Findings presented here include fecal 16S rRNA gene-based profiling and systemic and intestinal inflammatory biomarkers, including alpha (1)-acid glycoprotein (AGP), C-reactive protein (CRP), fecal myeloperoxidase (MPO), and calprotectin.ResultsStool samples were collected from 640 women (DRC, n = 157; India, n = 102; Guatemala, n = 276; and Pakistan, n = 105). Gut microbial community structure did not differ by intervention arm but changed significantly during pregnancy. Richness, a measure of alpha-diversity, decreased over pregnancy. Community composition (beta-diversity) also showed a significant change from first to third trimester in all four sites. Of the top 10 most abundant genera, unclassified Lachnospiraceae significantly decreased in Guatemala and unclassified Ruminococcaceae significantly decreased in Guatemala and DRC. The change in the overall community structure at the genus level was associated with a decrease in the abundances of certain genera with low heterogeneity among the four sites. Intervention arms were not significantly associated with inflammatory biomarkers at 12 or 34 weeks. AGP significantly decreased from 12 to 34 weeks of pregnancy, whereas CRP, MPO, and calprotectin did not significantly change over time. None of these biomarkers were significantly associated with the gut microbiota diversity.ConclusionThe longitudinal reduction of individual genera (both commensals and potential pathogens) and alpha-diversity among all sites were consistent and suggested that the effect of pregnancy on the maternal microbiota overrides other influencing factors, such as nutrition intervention, geographical location, diet, race, and other demographical variables.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.